![]() |
市場調查報告書
商品編碼
1345423
全球醫學影像市場 - 2023-2030Global Medical Imaging Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
概述
全球醫學影像市場在 2022 年達到 402 億美元,預計到 2030 年將達到 593 億美元,2023-2030 年預測期間年複合成長率為 5.1%。
醫學成像涉及對身體內部進行成像以進行臨床分析和醫療干涉的過程,以及某些器官或組織功能的視覺表示。每種類型的成像技術都會提供有關正在研究或治療的身體區域的不同資訊,這些資訊與可能的疾病、損傷或醫療治療的有效性相關。
醫學成像技術帶來了臨床解剖學和法醫病理學的巨大進步。新興技術使醫療保健專業人員能夠從不同的角度觀察和理解人體。常用的醫學成像設備包括X光、電腦斷層掃描(CT)、正電子發射斷層掃描(PET)、超音波和磁共振成像(MRI)。
此外,政府和私人組織投資增加、產品發布以及研發不斷增加等重要成長動力將推動未來市場的成長。 Koninklijke Philips NV、GE Healthcare、Shimadzu Corporation、Toshiba Medical Systems Inc. 等重要參與者都在市場上積極營運。
動力學
增加醫療成像設備的產品推出預計將推動市場成長
醫學成像設備廣泛用於診斷肌肉骨骼疾病、心臟病、癌症和慢性肺部疾病等慢性疾病。大公司的重大技術進步有助於推動市場成長。這些有效的產品發布有助於將研究發現轉化為新的治療方法,並改善對數百萬慢性病患者的護理。
例如,2023 年 7 月,柯尼卡美能達醫療保健美洲公司推出了 PocketPro H2,這是一款新型無線手持式超聲設備,用於照護端應用中的一般成像。 PocketPro H2 線性無線手持式超聲系統針對肌肉骨骼 (MSK)、疼痛管理、血管通路和針引導應用進行了最佳化。具有出色的圖像品質。
此外,飛利浦於 2023 年 5 月推出了飛利浦圖像引導治療移動 C 形臂系統 1000,名為 Zenition 10。飛利浦 Zenition 10 旨在通過提供速度和效率來解決高患者吞吐量問題。它還可以靈活地滿足創傷、骨科和其他手術領域的要求。因此,上述因素有助於提振市場。
政府和私人組織的投資刺激了其在全球市場的需求
政府在全球醫療設備的採購、定價和分銷方面發揮著重要作用。各國政府採取各種舉措來發展醫療保健基礎設施,以便為公眾提供安全且具有成本效益的醫療產品。政府機構的資助也有助於開設新設施。此外,實施符合進出口的法規預計將有助於為市場創造收入。
例如,2023 年 5 月,英國政府撥款 23 億英鎊建設 160 個新的社區診斷中心,以減輕 NHS 的壓力並改善患者護理。預計每年可提供超過 500,000 次額外檢查、成像和掃描。
此外,2023 年 3 月,加拿大全球醫療技術創新公司 Synaptive Medical Inc. 獲得加拿大出口發展局 (EDC) 4000 萬美元的投資,用於加速手術、成像和數據技術的發展。這筆 4000 萬美元的投資用於開發和擴大對加拿大製造的手術機器人、MRI 以及醫學成像和手術室數據平台的使用。
醫療成像設備的產品召回將阻礙全球醫療成像設備市場的成長
過去幾年,全球醫學成像市場發生了重大產品召回事件。當產品缺陷可能影響或傷害消費者、損害公司聲譽並阻礙市場成長時,就會發生產品召回。越來越多的此類事件導致不準確的錯誤,並且在醫學成像市場上出現了一些重大的產品召回事件。
例如,2022 年 5 月 26 日,雅培醫療在美國召回了 4,800 個 Dragonfly OpStar 成像導管。此外,2023 年 2 月,GE HealthCare 召回了一些可能導致嚴重傷害或死亡的核醫學成像系統。它屬於 GE 的核醫學 600 和 800 系列系統,用於檢測和診斷癌症和神經系統疾病。
Global Medical Imaging Market reached US$ 40.2 billion in 2022 and is expected to reach US$ 59.3 billion by 2030 growing with a CAGR of 5.1% during the forecast period 2023-2030.
Medical imaging involves the process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. Each type of imaging technology gives different information about the area of the body being studied or treated which is related to possible disease, injury, or the effectiveness of medical treatment.
Medical imaging techniques have led to great advances in clinical anatomy and forensic pathology. New and emerging technologies allow healthcare professionals to view and understand the human body from different perspectives. Commonly used medical imaging equipment includes X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound, and magnetic resonance imaging (MRI).
Furthermore, significant growth drivers such as the increasing investments by government and private organizations, product launches, and rising research and developments give rise to future market growth. Significant key players like Koninklijke Philips N.V., GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., and others are actively operating in the market.
Medical imaging devices are widely used in diagnosing chronic conditions like musculoskeletal disorders, cardiac disease, cancers, and chronic lung diseases. The major technological advancements by major companies help to drive market growth. These effective product launches help to transform research discoveries into new treatments and improve care for millions of people with chronic diseases.
For instance, in July 2023, Konica Minolta Healthcare Americas, Inc., launched PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications. The PocketPro H2 linear wireless handheld ultrasound system is optimized for musculoskeletal (MSK), pain management, vascular access, and needle guidance applications. with excellent image quality.
Additionally, in May 2023, Philips launched the Philips Image Guided Therapy Mobile C-arm System 1000, named Zenition 10. Philips Zenition 10 is designed to address high patient throughput by providing speed and efficiency. It also provides the flexibility to accommodate the requirements of trauma, orthopedics, and other areas of surgery. Thus, the above factors help to boost the market.
Government plays an important role in purchasing, pricing, and distributing medical devices globally. Governments undertake various initiatives to develop healthcare infrastructure to provide safe and cost-effective medical products to the public. The funding by government bodies also helps in opening new facilities. Also, implementing regulations that comply with imports and exports is expected to help generate revenue for the market.
For instance, in May 2023, the United Kingdom Government funded £2.3 billion into 160 new community diagnostic centers to reduce pressure on the NHS and improve patient care. It is expected to provide over 500,000 additional checkups, imaging, and scans a year.
Additionally, in March 2023, Synaptive Medical Inc., a global medical technology innovator in Canada, secured a USD $40 million investment from Export Development Canada (EDC) to accelerate surgical, imaging, and data technologies. The $40 million investment is to develop and expand access to Canadian-made surgical robotics, MRI, and data platforms for medical imaging and operating rooms.
The global medical imaging market has witnessed major product recalls in the past few years. Product recalls occur when a product defect could affect or harm the consumer, hampers a company's reputation, and hinders market growth. An increasing number of such instances result in inaccuracy errors and some major instances of product recall witnessed in the medical imaging market.
For instance, on 26 May 2022, Abbott Medical Recalled 4,800 Dragonfly OpStar Imaging Catheters in the U.S. Additionally, in February 2023, GE HealthCare recalled some of its nuclear medicine imaging systems that could cause serious injury or death. It pertains to GE's Nuclear Medicine 600 and 800 Series systems, used for detecting and diagnosing cancer, and neurological disorders.
The global medical imaging market is segmented based on product, application, end users, and region.
The X-ray segment has the most significant share of the medical imaging equipment market due to the system's versatility and convenience. An X-ray is a noninvasive medical imaging test that helps physicians diagnose and treat medical conditions. X-rays diagnose skeletal systems, oral cavities, lungs, breast, digestive systems, and ingested objects. The growth in the X-ray segment is mainly due to its cost-effectiveness
For instance, in July 2022, Shimadzu Corporation introduced a New Type of Mobile X-ray System Outside of Japan, accommodating a Wide Range of Needs for Mobile X-ray Systems. This system incorporates digital radiography (DR) and this Mobile X-ray system provides diagnostic imaging and can travel to patient rooms, operating rooms, and emergency areas.
For instance, on August 02, 2022, GE Healthcare launched its most advanced fixed X-ray system called the next-generation Definium 656 HD. The Definium 656 HD, featuring the Intelligent Workflow Suite, is a versatile and digital radiographic system powered by GE's FlashPad HD high-resolution detectors and the latest Helix 2.2 advanced image processing software.
North America has maintained a significant proportion of the medical imaging market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as rising product launches, healthcare expenditure, and research and developments in medical imaging equipment.
For instance, in August 2023, GE HealthCare launched the handheld ultrasound device Vscan Air SL. The dual-headed probe of Vscan Air SL enables clinicians to access sector and linear arrays on the same device that is capable of facilitating rapid vascular and cardiac assessments of patients.
The major global players in the market include: Koninklijke Philips N.V, GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., Ziehm Imaging Inc., Varian Medical Sytems, Aribex Corporation, Fujifilm Holdings Corporation, Siemens Healthcare, Hitachi Ltd. among others.
The COVID-19 pandemic has had a significant impact on the medical imaging market. During the height of the pandemic, many healthcare systems were overwhelmed, and non-urgent medical procedures and screenings were postponed or canceled. This led to delays in medical imaging device research and product launches. Clinical trials are vital for developing new treatments and improving outcomes in the medical imaging market.
However, the pandemic disrupted the conduct of clinical trials, with many sites temporarily halting enrollment or modifying protocols to prioritize patient safety. This has led to delays in the completion of trials and the availability of new therapies. Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical imaging market is expected to be moderately affected over the forecast period.
The global medical imaging market report would provide approximately 69 tables, 70 figures, and 195 Pages.
LIST NOT EXHAUSTIVE